Merck, which is evaluating the safety and efficacy of enlicitide for the treatment of adults with hyperlipidemia on lipid-lowering therapies, including at least a statin, said the Phase 3 studies met ...

The FTSE 100 and European stocks edged down on Monday as US and Chinese officials meet in London in a bid to make further ...

Two people were shot to death late Sunday night on the Las Vegas Strip and a suspect was being sought, police said, after ...

Futures on Wall Street are trading with modest loses ahead of important talks on the trade front and some inflation data that ...

Axsome Therapeutics received a refusal-to-file letter from the Food and Drug Administration for its new drug application for its fibromyalgia drug AXS-14.

While the Focused 50 Index itself is relatively new (launched in 2022), the strategy it represents can be tested over time using historical data.